Interferon

Treatment results often poor in those with hepatitis C virus genotype 4

Published in Hepatitis Weekly, September 23rd, 2002

by Sonia Nichols, senior medical writer - Patients infected with hepatitis C virus (HCV) genotype 4 do not respond well to prolonged treatment with either interferon monotherapy or interferon and ribavirin combination therapy.

Both therapeutic regimens are standard for individuals infected with HCV. However, after studying a cohort of 26 patients with HCV genotype 4-related cirrhosis who were given either of the regimens, investigators from the St. Johns Medical College Hospital in Karnataka, India, argue that neither regimen is very effective for such individuals.

The 26 patients were randomized to take interferon alone or interferon in combination...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry